1 |
Show member pathways
ILK Signaling
63
MAPK Signaling
63
Molecular Mechanisms of Cancer
63
Rho Family GTPases
63
|
13.65 |
PDGFRB PDGFRA KIT JAK2 FGFR1 CSF2 |
2 |
Show member pathways
all-trans-Retinoic Acid Signaling in Brain
63
Endothelin-1 Signaling Pathway
63
Glucocorticoid Receptor Signaling
63
IL-6 Pathway
63
MIF Mediated Glucocorticoid Regulation
63
MIF Regulation of Innate Immune Cells
63
NFAT Signaling and Lymphocyte Interactions
63
PGC1Alpha Pathway
63
RAR-Gamma-RXR-Alpha Degradation
63
STAT3 Pathway
63
|
13.5 |
PDGFRB PDGFRA KIT JAK2 FGFR1 EPO |
3 |
Show member pathways
JAK-STAT Pathway
63
JNK Pathway
63
MAPK Family Pathway
63
Regulation of eIF4 and p70S6K
63
SOCS Pathway
63
|
13.37 |
PDGFRB PDGFRA KIT JAK2 FGFR1 EPO |
4 |
Show member pathways
|
13.29 |
PDGFRB PDGFRA KIT JAK2 FGFR1 CSF2 |
5 |
Show member pathways
p38 Signaling
63
Tec Kinases Signaling
63
|
13.24 |
PDGFRB PDGFRA KIT JAK2 FGFR1 CSF2 |
6 |
Show member pathways
|
13.17 |
PDGFRB PDGFRA KIT JAK2 FGFR1 CSF2 |
7 |
Show member pathways
Antioxidant Action of Vitamin-C
63
Epithelial Adherens Junctions
63
|
13.1 |
PDGFRB PDGFRA KIT JAK2 FGFR1 CSF2 |
8 |
Show member pathways
mTOR Pathway
63
Renin-Angiotensin Pathway
63
|
12.88 |
PDGFRB PDGFRA KIT JAK2 FGFR1 |
9 |
Show member pathways
Actin Nucleation and Branching
63
CDC42 Pathway
63
RhoA Pathway
63
|
12.8 |
PDGFRB PDGFRA KIT FGFR1 |
10 |
Show member pathways
|
12.72 |
PDGFRB PDGFRA KIT JAK2 FGFR1 EPO |
11 |
Show member pathways
IGF1R Signaling
63
Signaling Involved in Cardiac Hypertrophy
63
|
12.71 |
PDGFRB PDGFRA JAK2 FGFR1 |
12 |
Show member pathways
Cell adhesion Integrin inside-out signaling
22
Development ACM2 and ACM4 activation of ERK
22
Development Angiotensin signaling via PYK2
22
Development EDNRB signaling
22
Development EPO-induced MAPK pathway
22
Development G-Proteins mediated regulation MARK-ERK signaling
22
Signal transduction IP3 signaling
22
|
12.62 |
PDGFRB PDGFRA KIT JAK2 EPO |
13 |
|
12.61 |
PDGFRB PDGFRA KIT FGFR1 |
14 |
Show member pathways
Signal transduction PTEN pathway
22
|
12.59 |
PDGFRB PDGFRA KIT FGFR1 CSF2 ABL1 |
15 |
Show member pathways
|
12.58 |
PDGFRB PDGFRA KIT FGFR1 |
16 |
Show member pathways
|
12.55 |
PDGFRB PDGFRA KIT FGFR1 ABL1 |
17 |
Show member pathways
|
12.46 |
PDGFRB PDGFRA JAK2 ABL1 |
18 |
Show member pathways
Cytoskeleton remodeling CDC42 in cellular processes
22
|
12.25 |
PDGFRB PDGFRA KIT FGFR1 |
19 |
|
12.22 |
PDGFRB PDGFRA KIT JAK2 FGFR1 EPO |
20 |
Show member pathways
|
12.04 |
PDGFRB PDGFRA KIT FGFR1 ABL1 |
21 |
Show member pathways
|
12.03 |
KIT JAK2 EPO |
22 |
Show member pathways
|
12.03 |
PDGFRB PDGFRA JAK2 EPO CSF2 ABL1 |
23 |
|
11.86 |
KIT EPO CSF2 |
24 |
|
11.76 |
KIT EPO CSF2 |
25 |
|
11.7 |
PDGFRB PDGFRA FGFR1 |
26 |
Show member pathways
|
11.66 |
PDGFRB KIT FGFR1 |
27 |
|
11.47 |
PDGFRB PDGFRA KIT FGFR1 |
28 |
|
11.35 |
PDGFRB PDGFRA FGFR1 |
29 |
|
11.3 |
PDGFRB PDGFRA FGFR1 |
30 |
Show member pathways
|
11.27 |
PDGFRB PDGFRA KIT ABL1 |
31 |
|
11.27 |
PDGFRB PDGFRA KIT JAK2 FGFR1 ABL1 |
32 |
Show member pathways
|
11.18 |
PDGFRB PDGFRA KIT |
33 |
|
11.02 |
PDGFRB PDGFRA |
34 |
|
10.85 |
PDGFRB PDGFRA KIT FGFR1 CSF2 |
35 |
|
10.77 |
PDGFRB PDGFRA |